Computational drug discovery for the Zika virus
Mottin, Melina, Borba, Joyce Villa Verde Bastos, Melo-Filho, Cleber Camilo, Neves, Bruno Junior, Muratov, Eugene, Torres, Pedro Henrique Monteiro, Braga, Rodolpho Campos, Perryman, Alexander, Ekins, Sean, Andrade, Carolina Horta
Braz. J. Pharm. Sci.
DATA DE PUBLICAÇÃO
Few Zika virus (ZIKV) outbreaks had been reported since its first detection in 1947, until the recent epidemics occurred in South America (2014/2015) and expeditiously became a global public health emergency. This arbovirus reached 0.5-1.3 million cases of ZIKV infection in Brazil in 2015 and rapidly spread in new geographic areas such as the Americas. Despite the mild symptoms of the Zika fever, the major concern is related to the related severe neurological disorders, especially microcephaly in newborns. Advances in ZIKV drug discovery have been made recently and constitute promising approaches to ZIKV treatment. In this review, we summarize current computational drug discovery efforts and their applicability to discovery of anti-ZIKV drugs. Lastly, we present successful examples of the use of computational approaches to ZIKV drug discovery.
- Drug discovery and computational strategies in the multitarget drugs era
- Computational Analysis of Plasmodium falciparum Metabolism: Organizing Genomic Information to Facilitate Drug Discovery
- Computational method for discovery of estrogen responsive genes
- Drug Discovery for Disorders of the Central Nervous System
- Harnessing DNA-Based Technology for Drug Discovery